Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
TOKYO, March 08, 2023--(BUSINESS WIRE)--Sumitomo Heavy Industries, Ltd. ("SHI") (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in...